Tags : Boris Wenger

Deal & transactions

Baker McKenzie advises Datwyler on the acquisition of CTsystems

Baker McKenzie Switzerland has advised publicly listed Datwyler, a specialist for system-critical elastomer components, on its acquisition of Swiss startup company CTsystems. With this acquisition, Datwyler is able to strengthen its position for the future technology of electroactive polymers by obtaining several patents of CTsystems. Electroactive polymers in a unique stacked design enable completely new […]

Deal & transactions

Baker McKenzie advises Helvetica Capital on acquisition of Schulthess Group

Baker McKenzie has advised Helvetica Capital and its Swiss entrepreneur investors in the acquisition of an additional participation in Schulthess Maschinen and its subsidiaries, a specialist producer of washing technology, equipment and system solutions, by way of acquiring an additional 26% stake in the parent company HC Holding Eta. This transaction makes Helvetica Capital and […]

Deal & transactions

Baker McKenzie advises ARGO-HYTOS in the sale of 79.5% of

Baker McKenzie has advised the two owners of ARGO-HYTOS Group, Christian Kienzle and FSP CAPCELLENCE, on selling their 79.5% of the shares in the company to Voith Group, a German industrial technology group. Through this deal, Voith has acquired a majority stake in Argo-Hytos, the Swiss hydraulic components manufacturer backed by mid-market sponsor Capcellence. A […]

Deal & transactions

Baker McKenzie advised Meier Capital on the sale of Barcol-Air

Investment Latour has, through its wholly-owned subsidiary Swegon Group, acquired Barcol-Air, a leading supplier of radiant ceiling systems. The acquisition of Barcol-Air means that Swegon continue to build on its already strong position within radiant ceilings, with the existing Zent-Frenger business. The acquisition makes it possible to go from being a strong player in Germany […]

Deal & transactions

Baker McKenzie advises Datwyler in its acquisition of QSR from

Datwyler, a provider of high-quality, system-critical elastomer components, has signed on 6 April 2022 an agreement to acquire the US company QSR from Q Holding and its private equity owner, 3i. The planned acquisition of QSR will strategically expand Datwyler’s existing portfolio and geographic footprint as Datwyler will expand in another attractive area of system-critical […]

Deal & transactions

Baker McKenzie advises Chord Therapeutics on its sale to Merck

Baker McKenzie advised Chord Therapeutics (Chord) and its shareholders on the sale of all the shares in Chord to Merck KGaA (Merck). The acquisition is subject to regulatory clearances. This strategic acquisition will enable Merck to expand its neurology portfolio in multiple sclerosis (MS). Chord is a Swiss-based biopharmaceutical company that develops drugs for patients with […]

Deal & transactions

Mérieux Equity Partners Invest EUR 40 mln in Swixx Biopharma

Mérieux Equity Partners, France (MxEP) has agreed to invest EUR 40 million into Swixx Biopharma, Switzerland (Swixx), taking a minority position. SIX listed HBM Healthcare Investments who had invested in Swixx in 2017, will co-invest alongside Mérieux, increasing HBM’s investment in Swixx by EUR 5 million. MxEP has arrangements in place to increase its investment […]

Deal & transactions

Dovista purchases Arbonia’s Windows Division: the advisors

The team was led by Markus Vischer (Partner, Corporate/M&A - pictured) and Samuel Lieberherr (Managing Associate, Corporate/M&A) and further included Michael Kündig (Senior Associate, Corporate/M&A), Reto Jacobs (Partner, Antitrust and Competition), Anna Baldenbach von Bröchen (Senior Associate, Corporate/M&A), Gion Giger (Counsel, Antitrust and Competition), Riccardo Brazerol (Associate, Corporate M&A), Sarah Eichenberger (Associate, Employment) and Dimitrios Berger (Associate, Corporate M&A).